Skip to main navigation Skip to search Skip to main content

In vitro activity of daptomycin against methicillin-resistant Staphylococcus aureus, including heterogeneously glycopeptide-resistant strains

  • Bram M.W. Diederen*
  • , Inge Van Duijn
  • , Piet Willemse
  • , Jan A.J.W. Kluytmans
  • *Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

30 Citations (Scopus)

Abstract

The purpose of the present study was to assess the in vitro activity of daptomycin against a well-defined collection of methicillin-resistant Staphylococcus aureus (MRSA) isolates (n = 98), including heterogeneously glycopeptide-resistant MRSA (hGISA) strains. Susceptibility testing was performed by using the Etest system. Daptomycin was potent against both glycopeptide-susceptible and hGISA strains.

Original languageEnglish
Pages (from-to)3189-3191
Number of pages3
JournalAntimicrobial Agents and Chemotherapy
Volume50
Issue number9
DOIs
Publication statusPublished - Sept 2006
Externally publishedYes

Fingerprint

Dive into the research topics of 'In vitro activity of daptomycin against methicillin-resistant Staphylococcus aureus, including heterogeneously glycopeptide-resistant strains'. Together they form a unique fingerprint.

Cite this